A Case of Toxoplasmosis Detected in Habitual Aborter.
- Author:
Se Yul HAN
;
Tae Ki YOON
;
Kwang Yul CHA
;
Dong Hee CHOI
;
Yoon Sung NAM
- Publication Type:Case Report
- Keywords:
Recurrent pregnancy loss;
Toxoplasmosis
- MeSH:
Birds;
Chemoprevention;
Clindamycin;
Encephalitis;
Humans;
Immunocompromised Host;
Infant;
Infant, Newborn;
Mammals;
Placenta;
Pyrimethamine;
Spiramycin;
Toxoplasma;
Toxoplasmosis*;
Toxoplasmosis, Congenital
- From:Korean Journal of Obstetrics and Gynecology
1999;42(2):436-438
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Toxoplasma gondii, an intracellular coccidian protozoan, is the causative agent of toxoplasmosis, a widespread infection affecting various birds and mammals including humans. In immunocompetent hosts, the infection is usually asymptomatic and benign. Toxoplasmosis is either congenital or acquired. In general prenatal therapy of congenital toxoplasmosis is beneficial in reducing the ncy of infant infection. Therapies are based primarily on spiramycin because of the relative lack of toxicity and high concentration achieved in the placenta. Clindamycin is the standard drug for chemoprophylaxis in newborn infants, and is directed at preventing the occurrence of retinochoroiditis as a late sequel to congenital infection. The standard treatment for acquired toxoplasmosis in both immunocompetent and immunodeficient patients is the synergistic combination of pyrimethamine and sulphonamides. Toxoplasmic encephalitis is tbe most common manifestation of acquired toxoplasmosis in immunocompromised patients and if not treated is fatal. However, because of toxicity, the therapeutic efficacy of pyrimethamine sulphonamide combinations may be seriously limited in immunodeficient patients. We have experienced a case of toxoplasmosis during the workup of habitual aborter. So we report this case with a brief review of literatures.
